NewG Lab Pharma, Inc. licensed in “KAT”
(Kodiscovery Anti-cancer Technology) from KoDiscovery, LLC.
(Indications: liver cancer, breast cancer, bladder cancer, melanoma)

Sponsored Research Agreement with NewG Lab Pharma, Inc.